Results 21 to 30 of about 117,600 (325)

Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly

open access: yesPharmaceuticals, 2021
Background: The objective of this study was to characterize individual case safety reports (ICSRs) and adverse drug reactions (ADRs) related to second-generation cephalosporins and resulting in hepatobiliary disorders, in VigiBase, WHO global database ...
Mariana Sipos   +5 more
doaj   +1 more source

Cephalosporin Antibiotics

open access: yesEar, Nose & Throat Journal, 1994
The last three decades have seen the emergence of a cornucopia of antimicrobials in the cephalosporin class. This becomes even more apparent when one realizes that over 60 pages of the 1993 AHFS drug information text is dedicated to the cephalosporin class.1 Due to similarities in nomenclature and the proliferation of available agents, the clinician ...
R A, Otto, A D, Noorily
openaire   +2 more sources

Epidemiological Trends of Antibiotic Resistant Gonorrhoea in the United Kingdom

open access: yesAntibiotics, 2018
Gonorrhoea is one of the most common sexually-transmitted bacterial infections, globally and in the United Kingdom. The levels of antibiotic resistance in gonorrhoea reported in recent years represent a critical public health issue.
Lilith K. Whittles   +3 more
doaj   +1 more source

Warfarin and Antibiotics: Drug Interactions and Clinical Considerations

open access: yesLife, 2023
Warfarin administration poses a notable challenge in clinical practice due to the increased susceptibility of patients to major bleeding, particularly when co-administered with other medications capable of modulating its metabolic pathways.
Alexis J. Vega   +8 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Healthcare associated Clostridioides difficile infection in adult surgical and medical patients hospitalized in tertiary hospital in Belgrade, Serbia: a seven years prospective cohort study

open access: yesLibyan Journal of Medicine, 2020
Introduction: Clostridioides difficile (C. difficile) infection (CDI) is one of the most common healthcare-associated (HA) infections in contemporary medicine.
Vesna Šuljagić   +8 more
doaj   +1 more source

Evaluation of the Efficacy and Safety of Initial Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Middle-Aged People

open access: yesБезопасность и риск фармакотерапии, 2022
β-lactam antibiotics, including cephalosporins, are the drugs of choice for empirical antibiotic therapy (ABT) in patients with community-acquired pneumonia.
T. V. Alexandrova   +9 more
doaj   +1 more source

Analysis of the Causes for Renal Dysfunction during Antibiotic Therapy in a Patient with Lyme Disease

open access: yesБезопасность и риск фармакотерапии, 2022
Adverse drug reactions (ADRs) are recorded throughout the lifecycle of a medicinal product. In the post-marketing period, new ADRs are primarily identified via drug safety signals.
N. Yu. Velts   +7 more
doaj   +1 more source

Repurposing clinically approved cephalosporins for tuberculosis therapy

open access: yesScientific Reports, 2016
While modern cephalosporins developed for broad spectrum antibacterial activities have never been pursued for tuberculosis (TB) therapy, we identified first generation cephalosporins having clinically relevant inhibitory concentrations, both alone and in
S. Ramón-García   +9 more
semanticscholar   +1 more source

Retrospective Analysis of the Safety of Antibacterial Medicinal Products for Elderly Patients with Community-Acquired Lower Respiratory Tract Infections

open access: yesБезопасность и риск фармакотерапии, 2023
Cephalosporins are the empirical antibiotic therapy (ABT) of choice for patients with community-acquired pneumonia (CAP). When treated with antibiotics, elderly patients, especially those with comorbidities, are at higher risk of developing adverse drug ...
G. I. Gorodetskaya   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy